Objective
Cells have a broad functional and morphological diversity due to differential gene expression. Research in epigenetics combines the study of inheritable, phenotypical changes in the gene expression pattern of a specific cell type that are not caused by a transformed nucleotide sequence of the genetic code itself. Epigenetic marks are represented by a variety of molecular mechanisms including DNA methylation. Alterations of DNA methylation play a crucial role in the onset of diseases like cancer. Many DNA methylation-based biomarkers have been evaluated and the analysis of epigenetic alterations is a promising tool for disease diagnostics, prognostics, and prediction of drug response. In future, this will allow to adapt therapies to a person, which will increase the chance for successful treatments, minimizing side-effects of chemotherapy and administration of ineffective drugs and thus, prevent the onset of follow-up problems that are associated with these events. Thus, cost-effective but robust means that allow the analysis of DNA methylation-based biomarkers are of urgent need. Several methods for analysis of these biomarkers are employed. However, those that have the required resolution are laborious, time-consuming, and error-prone and thus, prevent broad applications of DNA methylation profiling in clinical diagnostics. The aim of this project is to overcome the barriers that prohibit using DNA methylation profiling in broad clinical applications for diagnostics, prognostics, and prediction of drug response. The objectives will be reached by a multidisciplinary systemic approach harnessing the power of organic synthesis (i.e. new synthetic modified nucleotides), biochemical and structural enzyme studies, and directed evolution of DNA polymerases tailored for new replication systems for epigenetics. The evolved replication systems will be superior to known techniques by superseding the bottle necks of current approaches paving the way for broad applications.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences genetics DNA
- medical and health sciences clinical medicine oncology
- natural sciences biological sciences genetics nucleotides
- natural sciences biological sciences biochemistry biomolecules proteins enzymes
- natural sciences biological sciences genetics epigenetics
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
ERC-2013-ADG
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Host institution
78464 Konstanz
Germany
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.